Clinical use of biomarkers of survival in pulmonary fibrosis. - Wikidata - awgldk - TriplyDB

Clinical use of biomarkers of survival in pulmonary fibrosis.

Clinical use of biomarkers of survival in pulmonary fibrosis.

http://www.wikidata.org/entity/Q37768235

about

Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis: the need for early diagnosis Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.Treatment and monitoring of hypersensitivity pneumonitis.Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD.

P2860

Q30540289-B2805CDD-D08A-4D59-9CA0-D2F07333CF72 Q35207651-C52D05AC-240F-465F-8004-A35F94DD2951 Q35847544-2B79E2C6-7EEE-4E90-A9FC-3FDDE7152A0C Q35879613-470A737B-C727-4179-B25A-5AAF54ADC736 Q36251710-71A3FB2A-65FF-4CF5-8ABF-FD85630B8E69 Q37152292-EA1C88B5-ACBE-4118-9D2C-C78B9F396168 Q37485173-EBBC0701-A768-4EE7-9032-461713DA594E Q38818501-F583ECCD-EA24-43B8-B40B-BFF687F6495E Q48265029-50C4E8A0-69F3-4C2B-B06C-CDDC34B332BE

P2860

Clinical use of biomarkers of survival in pulmonary fibrosis.

http://www.wikidata.org/entity/Q37768235

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical use of biomarkers of survival in pulmonary fibrosis.

@en

Clinical use of biomarkers of survival in pulmonary fibrosis.

@nl

type

label

Clinical use of biomarkers of survival in pulmonary fibrosis.

@en

Clinical use of biomarkers of survival in pulmonary fibrosis.

@nl

prefLabel

Clinical use of biomarkers of survival in pulmonary fibrosis.

@en

Clinical use of biomarkers of survival in pulmonary fibrosis.

@nl

P1433

Q37768235-289B7173-0097-453B-A04A-AC748050C148

P1476

Q37768235-F3C8B5E5-B4E7-4008-9665-897FE86C2530

P2093

Q37768235-305BDC7E-D111-4805-A1D4-4CD9ABC5EFA2

Q37768235-6A15A26D-1A4B-46D9-B2EA-CF4FDC32B73E

Q37768235-D853A640-26CF-4D8F-B6C3-95F12D231F5A

Q37768235-FF2016CA-8E04-4170-BD98-42D17E06CE80

P2860

Q37768235-0DE972F1-B18A-4827-ADDD-0EE41172267D

Q37768235-10CEC6DF-0022-4093-84C2-E0D8D741C576

Q37768235-1B325321-DC16-4003-934B-B87FF5EB8F4A

Q37768235-1CA72613-34A1-4BC2-BF2E-0ABA2CD7277D

Q37768235-1EAF42EA-EE6A-4D3F-B40F-9BCD9F568D27

Q37768235-226AF246-D90D-4614-9B5C-CA13D3D894C5

Q37768235-257CF906-4766-4754-9DE2-33A9B7EEB4DC

Q37768235-285E1716-C304-4C56-A5C6-1D0E28955703

Q37768235-2AF0D407-1A27-4447-AA03-06D961455A2C

Q37768235-2AF0ED4F-6B88-4A8C-8832-CA881AA0D6BF

P2888

Q37768235-DE1C7F08-AC14-48B5-B72F-FBC68F919766

P304

Q37768235-3A98720C-3ACD-459A-A195-D0B05D2119A4

P31

Q37768235-85A86BC6-2042-4EB4-8690-8F5345C54129

P356

Q37768235-96DB4860-40AA-4783-9989-AF4A61C55745

P478

Q37768235-D01CE0B0-089F-4AD3-837B-ED91D4CE13D9

P50

Q37768235-E1D4D735-05B8-4C24-9012-994232D87A6C

P577

Q37768235-4C5A1409-7DD7-49D3-9E4C-D53A0712D941

P5875

Q37768235-EDB70240-C95D-4DA3-A247-0BBC18DBC594

P6179

Q37768235-20F3DC16-104C-42F2-9B18-F643D8CC12C1

P698

Q37768235-5F7A5CA4-A35D-474C-8C32-6AF3E4E0A01E

P921

Q37768235-0B3C449C-AABB-4022-9739-E7D7F2D0B0D4

Q37768235-49A88468-72DB-4D44-9276-622992361FD7

P932

Q37768235-1A811163-A314-4B2F-B22C-683302829D05

P356

1465-9921-11-89

P1433

Respiratory Research

P1476

Clinical use of biomarkers of survival in pulmonary fibrosis.

@en

P2093

Jan C Grutters

http://www.w3.org/2001/XMLSchema#string

Maurits G Demedts

http://www.w3.org/2001/XMLSchema#string

Stijn Willems

http://www.w3.org/2001/XMLSchema#string

Wim A Wuyts

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of progression in idiopathic pulmonary fibrosis

Determinants of survival in idiopathic pulmonary fibrosis

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

High-dose acetylcysteine in idiopathic pulmonary fibrosis

Standardisation of spirometry

The clinical course of patients with idiopathic pulmonary fibrosis.

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.

P2888

1465-9921-11-89

P304

89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-11-89

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Michiel Thomeer

P577

2010-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45264135

http://www.w3.org/2001/XMLSchema#string

P6179

1007810395

http://www.w3.org/2001/XMLSchema#string

P698

20584284

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

2907324

http://www.w3.org/2001/XMLSchema#string